Who founded Calithera Biosciences?

Calithera Biosciences was founded by Susan M. Molineaux in 2010.

Who are Calithera Biosciences's investors?

Calithera Biosciences's investors include Longwood Fund, Venture Capital Investment Management, The Column Group.

How much funding has Calithera Biosciences raised?

Calithera Biosciences has disclosed $16M raised across 1 round.

Where is Calithera Biosciences headquartered?

Calithera Biosciences is headquartered in South San Francisco, US.

Calithera Biosciences

Defunct

South San Francisco, US · Founded 2010 · 25 employees on LinkedIn · 3 known investors

Find your way into Calithera Biosciences

184 people in our graph share verified history with the Calithera Biosciences team — schools, employers, funds. One of them is your warm intro.

Casper de Clercqunlockedknows William Waddill · together at Ilypsa, Inc. (overlapped)

knows the team · via Calithera Biosciences

×4knows the team · via Protagonist Therapeutics

×4knows the team · via Arrowhead Pharmaceuticals

×2knows the team · via Annexon

Calithera Biosciences was a clinical-stage biopharmaceutical company developing small-molecule oncology drugs targeting tumor metabolism, including the glutaminase inhibitor telaglenastat.

Biotech

Founders & leadership

Calithera Biosciences was founded in 2010 by Susan M. Molineaux.

Susan M. Molineaux Founder · President and Chief Executive OfficerSusan M. Molineaux co-founded Calithera Biosciences in 2010 and serves as President and CEO. She previously co-founded Proteolix in 2003, where she held senior scientific and leadership roles and led development of the proteasome inhibitor carfilzomib; Proteolix was acquired by Onyx Pharmaceuticals in 2009. Molineaux holds a B.S. in Biology from Smith College, a Ph.D. in Molecular Biology from Johns Hopkins University, and completed a postdoctoral fellowship at Columbia University.

William Waddill Sr. Vice President, Chief Financial Officer2014–2016William Waddill served as Senior Vice President and CFO at Calithera Biosciences, where he oversaw equity financing including an $80 million IPO in 2014. He holds a BS in accounting from the University of Illinois, Chicago, and has spent over 30 years in biotechnology finance following early career roles in commercial banking and public accounting at PwC and Deloitte.

Board

Jean M. GeorgeBoard director

Deepa Pakianathan Lead Director and Independent Board Member2010–2023General Partner at Delphi Ventures

Ralph E. ChristoffersenBoard director

Jonathan DrachmanBoard director

Investors · 3

Longwood Fundlisted by Longwood FundBoston

How we know: Longwood Fund's portfolio page · Not right? Tell us

Venture Capital Investment Managementlisted by Venture Capital Investment ManagementSan Francisco

How we know: Venture Capital Investment Management's portfolio page · Not right? Tell us

The Column GroupreportedSan Francisco · $30M

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$16M disclosed across 1 round · 2014

▶$16MraisedJul 2014 · 19 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Susan M. MolineauxExecutive Officer, Director
Jean M. GeorgeDirector
William WaddillExecutive Officer
Deepa PakianathanDirector
Jonathan DrachmanDirector
Ralph E. ChristoffersenDirector

Offering amount: $30M
Amount sold: $16M
First sale: Jul 2014
Incorporated: Corporation, Delaware, 2010
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Calithera Biosciences do?: Calithera Biosciences was a clinical-stage biopharmaceutical company developing small-molecule oncology drugs targeting tumor metabolism, including the glutaminase inhibitor telaglenastat.
Who founded Calithera Biosciences?: Calithera Biosciences was founded by Susan M. Molineaux in 2010.
Who are Calithera Biosciences's investors?: Calithera Biosciences's investors include Longwood Fund, Venture Capital Investment Management, The Column Group.
How much funding has Calithera Biosciences raised?: Calithera Biosciences has disclosed $16M raised across 1 round.
Where is Calithera Biosciences headquartered?: Calithera Biosciences is headquartered in South San Francisco, US.